The Form 4 filing was submitted on Nov. 12, 2026, for sales made on Nov. 11. Form 4 is an SEC report of insider stock trades. Joshua Jergensen serves as president and chief operating officer of PACS Group, Inc..
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-11 |
| Date of Latest Transaction | 2026-11-11 |
| Buy/Sell | sell |
| Transaction Count | 3 |
| Shares Transacted | 40,000 |
| Price | $50.11 |
| Total Transaction Value | $2,004,319.69 |
| Insider | |
| Ticker Symbol | PACS |
| Company | PACS Group, Inc. |
| Insider Name | Jergensen Joshua |
| Insider Title | President & COO |
| Sector - Industry | Healthcare - Medical Care Facilities |
| Holdings | |
| Total Shares Owned After Transaction | 2,416,320 |
| Position Size Change | 1.63% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales, reported under transaction code S. The filing covers three sale transactions by one insider. All three appear in the same filing.
What was the average price of the transaction?
The average sale price was $50.11 per share, rounded to cents. This average covers the 40,000 shares sold across the three transactions.
How did this transaction affect the insider's holdings?
Joshua Jergensen sold 40,000 shares and reported owning 2,416,320 shares afterward. The shares sold made up 1.63% of his reported shares owned before the sales.
What's the total transaction value?
The total sale value was $2,004,319.69, rounded to cents. That amount covers all 40,000 shares across the three sales.
Are there any special circumstances around this transaction?
The filing information includes a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. The footnote text is unavailable, so it is unclear which of the three sales the reference covers. The plan's start date, trading schedule and other terms remain unknown.
For research purposes only; not investment advice.